1982
DOI: 10.1152/ajprenal.1982.242.4.f385
|View full text |Cite
|
Sign up to set email alerts
|

In vivo biosynthesis and turnover of glomerular basement membrane in diabetic rats

Abstract: Glomerular basement membrane (GBM) was labeled in vivo by the injection of tracer amounts of tritiated proline into normal and streptozotocin-diabetic rats. Basement membrane biosynthesis and turnover were determined from the specific activities of proline and hydroxyproline in samples purified following osmotic lysis of glomeruli isolated 4 h to 12 days after injection. Peak radiolabeling of normal and diabetic GBM occurred within 24-48 h and 48-72 h, respectively, and, when corrected for differences in the s… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

5
17
0

Year Published

1982
1982
1999
1999

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 21 publications
(22 citation statements)
references
References 0 publications
5
17
0
Order By: Relevance
“…Taken together, the data suggest that a decrease in the degradation of both type-IV collagen and fibronectin may contribute to the accumulation of these basement membrane components, under conditions of elevated D -glucose. The data support the hypothesis that decreased degradation of tubular basement membrane components may contribute to tubular basement membrane thickening in diabetic nephropathy, and is consistent with in vivo observations on the turnover of glomerular basement membrane in streptozotocin-induced diabetic rats [32]. …”
Section: Discussionsupporting
confidence: 90%
“…Taken together, the data suggest that a decrease in the degradation of both type-IV collagen and fibronectin may contribute to the accumulation of these basement membrane components, under conditions of elevated D -glucose. The data support the hypothesis that decreased degradation of tubular basement membrane components may contribute to tubular basement membrane thickening in diabetic nephropathy, and is consistent with in vivo observations on the turnover of glomerular basement membrane in streptozotocin-induced diabetic rats [32]. …”
Section: Discussionsupporting
confidence: 90%
“…It has been reported that advanced glycation end products (AGEs), which are non-enzymatically glycated proteins, contribute to the pathogenesis of diabetic nephropathy and may be associated with the balance between turnover and degradation of ECM [6, 7, 8, 85, 86, 87, 88]. We have reported that a monoclonal anti-AGE antibody reacted with the mesangial area in patients with diabetic nephropathy and that the intensity of AGE staining gradually increased in parallel with the degree of mesangial expansion [7].…”
Section: Regulation Of Ecm Production and Degradation In Diabetic Nepmentioning
confidence: 99%
“…Moreover, we showed that a monoclonal antibody to reduced glycated lysine reacted with GBM in the glomeruli of diabetic nephropathy patients [8]. AGEs stimulate matrix production and inhibit mesangial proliferation [85]and glycated GBM is more resistant to digestion by protease [86]. Doi et al [87]showed that mouse mesangial cells exhibited an increase in mRNA and peptide synthesis of type IV collagen, laminin and heparan sulfate proteoglycan after exposure to AGEs.…”
Section: Regulation Of Ecm Production and Degradation In Diabetic Nepmentioning
confidence: 99%
“…The pathogenesis of diabetic microangiopathy remains enigmatic, despite the acquisition of a great deal of knowledge concerning functional (1)(2)(3), biochemical (4), and morphological changes (5) in the vasculature of diabetic patients. These characteristic changes include increased regional vascular flow (1,2), increased microvascular permeability (3), capillary basement membrane thickening (4), and the presence of microaneurysms and neovascularization (5). It is likely that endothelial cells play an important role in the development of microangiopathy.…”
Section: Introductionmentioning
confidence: 99%